1. 164: PARIS: A phase I study of pembrolizumab anti-PD-1 monoclonal antibody in combination with radiotherapy (RT) in locally advanced non-small cell lung cancer (NSCLC). (January 2017) Authors: Kordbacheh, T.; Chan, C.; Bossons, A.; Franks, K.; McDonald, F.; Forster, M.; Mendes, R.; Quezada, S.; Dovedi, S.; Ralph, C.; Popat, S.; Harrington, K.; Melcher, A.; Popple, A.; Illidge, T.; Faivre-Finn, C. Journal: Lung cancer Issue: Volume 103(2017)Supplement 1 Page Start: S75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 168: PD-RAD: A translational study investigating PD-L1 expression after radiotherapy for non-small cell lung cancer (NSCLC). (January 2017) Authors: Kordbacheh, T.; Chan, C.; Faivre-Finn, C.; Franks, K.; McDonald, F.; Forster, M.; Mendes, R.; Quezada, S.; Dovedi, S.; Ralph, C.; Popat, S.; Harrington, K.; Melcher, A.; Popple, A.; Illidge, T. Journal: Lung cancer Issue: Volume 103(2017)Supplement 1 Page Start: S78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0868 A Preliminary Exploration of the Effect of Two Different Acceptability Statement Strategies on Estimates of Patient Acceptable Symptomatic State (Pass) in Osteoarthritis (OA). (9th June 2015) Authors: Bellamy, N.; Kearey, P.; Popple, A. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Immune Checkpoint Inhibitors in Lung Cancer – An Unheralded Opportunity?. Issue 4 (April 2017) Authors: Marshall, R.; Popple, A.; Kordbacheh, T.; Honeychurch, J.; Faivre-Finn, C.; Illidge, T. Journal: Clinical oncology Issue: Volume 29:Issue 4(2017) Page Start: 207 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗